1 Result(s)

Article

PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice

Several lipid guidelines recommend that proprotein convertase subtilisin/kexin type 9 inhibitors should be considered for patients with atherosclerotic cardiovascular disease who are inadequately treated with ...

Klaus G. Parhofer, Berndt von Stritzky, Nicole Pietschmann… in Drugs - Real World Outcomes (2019)